Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2289 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorised and registered share capital at the end of the month. The report also includes information on issued shares and public float sufficiency confirmation. The company confirms compliance with public float requirements as of the end of the reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Charmacy Pharmaceutical Co., Ltd. on 6ix
Earlier from Charmacy Pharmaceutical
- 2026 Interim report
- Exchange notice - trading halt
- Form of proxy for use at the annual general meeting to be held at the conference room on 3rd floor, no. 235 song shan north road, longhu district, shantou city, guangdong province, the prc on 31 May 2021 at 10 a.m. or at any adjournment thereof
- (1) Proposed election of directors of the third session of the board; and (2) proposed election of shareholder representative supervisor and independent supervisor of the third session of the supervisory committee
- Change of building name of principal place of business in hong kong
Follow Charmacy Pharmaceutical into a list and get an email when it puts out news.
Follow Charmacy Pharmaceutical